Both in Pharmaceuticals
Omeros vs Amphastar Pharmaceuticals
Over the past year OMER returned +155.1% and AMPH returned +10.3%; their daily moves had a correlation of 0.05.
OMER +155.1% AMPH +10.3%Growth of $1, one year, split-adjusted
| Metric | OMER | AMPH |
|---|---|---|
| Price | $17.17 | $27.86 |
| Market cap | $1.24B | $1.18B |
| Today | −5.56% | −0.59% |
| 1 month | −8.4% | +9.1% |
| 6 months | +17.3% | +15.9% |
| Year to date | 0.0% | +4.0% |
| 1 year | +155.1% | +10.3% |
| Revenue growth (YoY) | — | +5.4% |
| Gross margin | 97.2% | 50.8% |
| Net margin | 46.4% | 16.5% |
| P/E (TTM) | 10.0× | 15.1× |
| Price / sales | 32.3× | 1.6× |
| Net cash | $58.7M | -$321.9M |
| Dividend yield | — | — |
| Volatility (60d) | 77.7% | 30.8% |
| Short % of float | 17.8% | 14.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).